Clinical trial
Efficacy of Dapsone as a Steroid Sparing Agent in Pemphigus Vulgaris
NCT00429533 · Jacobus Pharmaceutical, Industry · Terminated
Key facts
| NCT number | NCT00429533 |
|---|---|
| Title | Efficacy of Dapsone as a Steroid Sparing Agent in Pemphigus Vulgaris |
| Official title | A Prospective Randomized Placebo-Controlled Clinical Trial of Dapsone as a Glucocorticoid-Sparing Agent in Maintenance Phase Pemphigus Vulgaris |
| Lead sponsor | Jacobus Pharmaceutical, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pemphigus Vulgaris |
| Intervention type | Drug |
| Interventions | Dapsone |
| Enrollment | 48 |
| Start date | Nov 1, 1996 |
| Completion | Feb 1, 2004 |
| First posted | Jan 31, 2007 |
| Last update posted | Feb 5, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: